MedPath

BUTALBITAL, ACETAMINOPHEN AND CAFFEINE

Butalbital, Acetaminophen and Caffeine Tablets, USP 8239601/0817 Rx only

Approved
Approval ID

92a81a1f-698b-4db0-b5a6-f7562abd9a32

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 10, 2022

Manufacturers
FDA

Cardinal Health 107, LLC

DUNS: 118546603

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

BUTALBITAL, ACETAMINOPHEN AND CAFFEINE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code55154-7147
Application NumberANDA040511
Product Classification
M
Marketing Category
C73584
G
Generic Name
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
Product Specifications
Route of AdministrationORAL
Effective DateApril 21, 2021
FDA Product Classification

INGREDIENTS (8)

SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
BUTALBITALActive
Quantity: 50 mg in 1 1
Code: KHS0AZ4JVK
Classification: ACTIB
ACETAMINOPHENActive
Quantity: 325 mg in 1 1
Code: 362O9ITL9D
Classification: ACTIB
CAFFEINEActive
Quantity: 40 mg in 1 1
Code: 3G6A5W338E
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BUTALBITAL, ACETAMINOPHEN AND CAFFEINE - FDA Drug Approval Details